FDA Inspection
The American National Red CrossThe American National Red Cross – FDA Inspection, Sep 25, 2020
Record Details
This FDA Inspection record concerns The American National Red Cross, with an inspection on September 25, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- September 25, 2020
- Product Type
- Biologics
View Company Profile
ID · 7bca0dab-1752-42ae-a09f-d2336b72896d
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1130878
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of The American National Red Cross
12| Date | Classification | Office | Project area |
|---|---|---|---|
| March 19, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 18, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 23, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 9, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 11, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for The American National Red Cross
- FDA Inspection 1309930 - 2026-03-19
- FDA Inspection 1217529 - 2023-08-18
- FDA Inspection 1042854 - 2018-02-23
- FDA Inspection 952327 - 2015-12-09
- FDA Inspection 941638 - 2015-09-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.